Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants

Pediatric Infectious Disease Journal

Volumn 16, Issue 9, 1997, Pages 863-870

  Pichichero, Michael E ^a,f   Latiolais, Thomas ^b   Bernstein, David I ^c   Hosbach, Philip ^d   Christian, Edward ^d   Vidor, Emmanuel ^d   Meschievitz, Carlton ^d   Daum, Robert S ^e  

^a UNIVERSITY OF ROCHESTER   (United States)

^b Highland Clinic   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d Pasteur Merieux Connaught   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Clinical trials; Haemophilus influenzae type b vaccine; Pertussis vaccine; Vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; ORAL POLIOMYELITIS VACCINE; TETANUS TOXOID; TREPEDIA; TRIHIBIR; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DRUG SAFETY; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MULTICENTER STUDY; POLIOMYELITIS; PRIORITY JOURNAL; VACCINATION;

ANALYSIS OF VARIANCE; ANTIGENS, BACTERIAL; CHI-SQUARE DISTRIBUTION; DIPHTHERIA TOXOID; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DRUG INTERACTIONS; FEMALE; FOLLOW-UP STUDIES; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; POLIOVIRUS VACCINE, ORAL; PROSPECTIVE STUDIES; TETANUS TOXOID; VACCINES, COMBINED; VACCINES, CONJUGATE;

EID: 0030822562     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199709000-00009     Document Type: Article

References (39)

1. Insel RA. Potential alterations in immunogenicity by combining or simultaneously administering vaccine components. Ann NY Acad Sci 1995;754:35-47.
2. Clemens J, Ferreccio C, Levine M, et al. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. JAMA 1992;267:673-8.
3. Paradiso P, Hogerman D, Madore D, et al. Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants. Pediatrics 1993;92:827-32.
4. Mulholland E, Ahonkhai V, Greenwood A, et al. Safety and immunogenicity of Haemophilus influenzae type b-Neisseria meningitidis Group B outer membrane complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infants. Pediatr Infect Dis J 1993;12:632-7.
5. Kaplan SL, Lauer BA, Ward BA, et al. Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants. J Pediatr 1994;2:323-7.
6. Ferreccio C, Clemens J, Avendano A, et al. The clinical and immunologic response to Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1991;10:764-71.
7. Avendano A, Ferreccio C, Lagos R, et al. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1993;12:638-43.
8. Miller MA, Meschievitz CK, Ballanco GA, Daum RS. Safety and immunogenicity of PRP-T combined with DPT: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Pediatrics 1995;95:522-7.
9. Rennels MB, Reed GF, Decker MD, et al. Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines. Pediatrics 1995;96(Suppl):576-9.
10. Pichichero ME, Francis AB, Blatter MM, et al. Acellular pertussis vaccination of 2-month-old infants in the United States. Pediatrics 1992;89:882-7.
11. Anderson P. Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type b. J Immunol 1978;120:866-70.
12. Hollinger FB, Adam E, Heiberg D, Melnick JL. Response to hepatitis B vaccine in a young adult population. In: Bamuness W, Alter HJ, Maynard JE, eds. Viral hepatitis: 1981 International Symposium. Philadelphia: Franklin Institute Press, 1981:451-66.
13. Albrecht P, van Steenis G, van Wezel AL, Salk J. Standardization of poliovirus neutralizing antibody tests. Rev Infect Dis 1984;6:S540-4.
14. Daum RS. Efficacy of the combined diphtheria-tetanus toxoids-pertussis-Haemophilus conjugate vaccine. Pediatr Infect Dis J 1995;14:640-1.
15. Ambrosino D, Schreiber JR, Daum RS, Siber GR. Efficacy of human hyperimmune globulin in prevention of Haemophilus influenzae type b disease in infant rats. Infect Immun 1983; 39:709-14.
16. Santosham M, Reid R, Ambrosino DM, et al. Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin. N Engl J Med 1987;317:923-9.
17. Peltola H, Kayhty H, Virtaneon M, Makela PH. Prevention of Haemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med 1984;310: 1561-6.
18. Robbins JB, Parke JC Jr, Schneerson R, Whisnant JK. Quantitative measurements of "natural" immunization induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res 1973;7:103-10.
19. Kayhty H, Peltola H, Karanko V, Makela PH. The protective titer of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
20. Anderson P. The protective level of serum antibodies to the capsular polysaccharide of H. influenzae type b. J Infect Dis 1984;149:1034-5.
21. Weinberg GA, Einhorn MS, Lenoir AA, Granoff PD, Granoff DM. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. J Pediatr 1987;111:22-7.
22. Anderson P, Pichichero M, Edwards K, Porch CR, Insel R. Priming and induction of Haemophilus influenzae type b capsular antibodies by Dpo20, an oligosaccharide-protein conjugate vaccine. J Pediatr 1987;111:644-50.
23. Stein KE. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis J 1992;165: S49-52.
24. Pichichero ME, Passador S. Response to Haemophilus influenzae b (Hib) conjugate vaccine booster following DTaP-HB-Hib combination vaccine in infants: evidence of priming. Clin Infect Dis (in press).
25. Eskola J, Olander FM, Litmanen L, Saarinen L, Bogaerts H, Kayhty H. Hib antibody response after two doses of combined DTPa-Hib conjugate vaccine as compared to separate injections [Abstract G11]. In: Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 18 to 20, 1995. Washington, DC: American Society for Microbiology, 1995.
26. Schmitt HJ. Immunogenicity and reactogenicity of 2 Hib tetanus conjugate vaccines administered by reconstituting with DTPa or given as separate injections [Abstract G63]. In: Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 18 to 20, 1995. Washington, DC: American Society for Microbiology, 1995.
27. Shinefield H, Black S, Ray P, Lewis E, Fireman B. Safety of combined acellular pertussis DTaP-HbOC vaccine (Lederle-Praxis) in infants [Abstract G72]. In: Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 18 to 20, 1995. Washington, DC: American Society for Microbiology, 1995.
28. Lenoir AA, Granoff PD, Granoff DM. Immunogenicity of Haemophilus influenzae type b polysaccharide-Nesseria meningitidis outer membrane protein conjugate vaccine in 2-to 6-month-old infants. Pediatrics 1987;80:283-7.
29. Santosham M, Wolff M, Reid R, et al. The efficacy of Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med 1991;324: 1767-72.
30. Miller MA, Meschievitz CK, Ballanco GA, Daum RS. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Pediatrics 1995;95: 522-7.
31. Kaplan SL, Lauer BA, Ward MA, et al. Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants. J Pediatr 1994;124:323-7.
32. Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr 1992;120(2 Pt 1):184-9.
33. Granoff DM, Anderson EL, Osterholm MT, et al. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J Pediatr 1992;121:187-94.
34. Granoff DM, Holmes SJ, Osterholm MT, et al. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis 1993;168: 663-71.
35. Kurikka S, Kayhty H, Saarinen L, Ronnberg PR, Eskola J, Makela PH. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy. J Infect Dis 1995;172:1268-72.
36. Decker MD, Edwards KM, Bradley R, Palmer P. Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid. J Pediatr 1993;122:410-13.
37. Scheifele D, Law B, Mitchell L, Ochnio J. Study of booster doses of two Haemophilus influenzae type b conjugate vaccines including their interchangeability. Vaccine 1996;14: 1399-406.
38. Zepp F, Schmitt HJ, Kaufhold A, et al. Evidence for induction for polysaccharide specific B-cell-memory in the first year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. Eur J Pediatr 1997;156:18-24.
39. Rothstein EP, Kamiya H, Nii R, et al. Comparison of diphtheria-tetanus-two component acellular pertussis vaccines in United States and Japanese Infants at 2, 4, and 6 months of age. Pediatrics 1996;97:236-42.